FORMULE SOMMEIL
Natural health product licensed in Canada
- Licence holder
- Idunn Technologies Inc.
- NPN or DIN-HM
- 80053923
- Status
- Active licence
- Licence date
- 16 September 2014
- Revision date
- 10 September 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]acétamide Source : Mélatonine | 5 mg | Not calculated |
| Valeriana officinalis Source : Valeriana officinalis - Racine Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 900 mg Potency : 0.8 % acide valérénique | 150 mg | Not calculated |
| Olea europaea Source : Olea europaea - Fruit Extract : Matériel brut frais Extraction ratio : 10:1 Dry plant equivalent : 1,750 mg Potency : 1.5 % 3,4-dihydroxyphényléthanol | 175 mg | Not calculated |
| Passiflora incarnata Source : Passiflora incarnata - Herb top Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 600 mg | 150 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Silice, Hypromellose, Cellulose - microcrystalline, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | minimum: 1 Tous les jours ; maximum: 1 Tous les jours |
Uses authorised in Canada
Aide à réduire le temps nécessaire pour s'endormir. Aide à augmenter la durée totale du sommeil et la qualité, chez les personnes souffrant de restriction du sommeil ou d'horaire altéré du sommeil, par exemple le travail à horaires variables et le décalage horaire. Utilisée traditionnellement en phytothérapie pour aider à dormir. Aide à soulager la nervosité. Fournit des antioxydants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Si vous êtes enceinte ou allaitez, ne pas utiliser ce produit
Source
Official Health Canada record, licence 80053923
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.